-transparent.png){kind=logo}
The bioavailability of tranexamic acid after the administration of a single intramuscular dose was estimated in three healthy male volunteers. 500 mg tranexamic acid were given intramuscularly and intravenously, as a bolus injection, to each subject on separate occasions. Following intramuscular administration, the peak plasma concentrations were attained after approximately one hour and the apparent elimination half-life was about two hours. The absolute bioavailability was 105.2 +/- 10.7% (mean +/- SD). At the dose given, the bioavailability of tranexamic acid after intramuscular administration is fast and complete.
Related Publications
E Puigdellívol, and
M E Carral, and
J Moreno, and
J M Plà-Delfina, and
F Jané
January 1981,
European journal of clinical pharmacology,
E Puigdellívol, and
M E Carral, and
J Moreno, and
J M Plà-Delfina, and
F Jané
September 2009,
International journal of clinical pharmacology and therapeutics,
E Puigdellívol, and
M E Carral, and
J Moreno, and
J M Plà-Delfina, and
F Jané
August 1982,
British journal of clinical pharmacology,
E Puigdellívol, and
M E Carral, and
J Moreno, and
J M Plà-Delfina, and
F Jané
January 2021,
British journal of anaesthesia,
E Puigdellívol, and
M E Carral, and
J Moreno, and
J M Plà-Delfina, and
F Jané
January 2014,
Clinical pharmacology in drug development,
E Puigdellívol, and
M E Carral, and
J Moreno, and
J M Plà-Delfina, and
F Jané
April 1999,
Biopharmaceutics & drug disposition,
E Puigdellívol, and
M E Carral, and
J Moreno, and
J M Plà-Delfina, and
F Jané
August 1979,
Journal of pharmacokinetics and biopharmaceutics,
E Puigdellívol, and
M E Carral, and
J Moreno, and
J M Plà-Delfina, and
F Jané
January 1997,
European journal of clinical pharmacology,
E Puigdellívol, and
M E Carral, and
J Moreno, and
J M Plà-Delfina, and
F Jané
January 1996,
European journal of clinical pharmacology,
E Puigdellívol, and
M E Carral, and
J Moreno, and
J M Plà-Delfina, and
F Jané
January 2021,
British journal of anaesthesia,
